The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Joy Melnikow

Department of Economics

Center for Healthcare Policy and Research

University of California

Davis

USA

[email]@ucdavis.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Economics, Center for Healthcare Policy and Research, University of California, Davis, USA. 1997 - 2010
  • UC Davis-Sacramento Medical Center, Sacramento, California, USA. 1996

References

  1. Surveillance after treatment for cervical intraepithelial neoplasia: outcomes, costs, and cost-effectiveness. Melnikow, J., Kulasingam, S., Slee, C., Helms, L.J., Kuppermann, M., Birch, S., McGahan, C.E., Coldman, A., Chan, B.K., Sawaya, G.F. Obstet. Gynecol (2010) [Pubmed]
  2. Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study. Melnikow, J., McGahan, C., Sawaya, G.F., Ehlen, T., Coldman, A. J. Natl. Cancer Inst. (2009) [Pubmed]
  3. Tamoxifen for breast cancer risk reduction: impact of alternative approaches to quality-of-life adjustment on cost-effectiveness analysis. Melnikow, J., Birch, S., Slee, C., McCarthy, T.J., Helms, L.J., Kuppermann, M. Med. Care (2008) [Pubmed]
  4. Chemoprevention: drug pricing and mortality: the case of tamoxifen. Melnikow, J., Kuenneth, C., Helms, L.J., Barnato, A., Kuppermann, M., Birch, S., Nuovo, J. Cancer (2006) [Pubmed]
  5. Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction. Melnikow, J., Paterniti, D., Azari, R., Kuenneth, C., Birch, S., Kuppermann, M., Nuovo, J., Keyzer, J., Henderson, S. Cancer (2005) [Pubmed]
  6. Management of the low-grade abnormal Pap smear: What are women's preferences?. Melnikow, J., Kuppermann, M., Birch, S., Chan, B.K., Nuovo, J. J. Fam. Pract (2002) [Pubmed]
  7. Vaginal birth after cesarean in California. Melnikow, J., Romano, P., Gilbert, W.M., Schembri, M., Keyzer, J., Kravitz, R.L. Obstet. Gynecol (2001) [Pubmed]
  8. Put prevention into practice: a controlled evaluation. Melnikow, J., Kohatsu, N.D., Chan, B.K. Am. J. Public. Health (2000) [Pubmed]
  9. Do follow-up recommendations for abnormal Papanicolaou smears influence patient adherence?. Melnikow, J., Chan, B.K., Stewart, G.K. Arch. Fam. Med (1999) [Pubmed]
  10. Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Melnikow, J., Nuovo, J., Willan, A.R., Chan, B.K., Howell, L.P. Obstet. Gynecol (1998) [Pubmed]
  11. Detection of high-grade cervical dysplasia: impact of age and Bethesda system terminology. Melnikow, J., Nuovo, J., Paliescheskey, M., Stewart, G.K., Howell, L., Green, W. Diagn. Cytopathol. (1997) [Pubmed]
  12. Calcium supplementation during pregnancy. Melnikow, J.A. J. Fam. Pract (1996) [Pubmed]
 
WikiGenes - Universities